For L4-L5 herniations, BPC-157 injections should target the lower lumbar region approximately at the level of the iliac crest (top of the hip bone), which corresponds roughly to the L4-L5 level
Renal clearance of peptides varies with glomerular filtration rate, and no dose-adjustment guidance exists because no human pharmacokinetic study has been completed
Since BPC-157 is not approved by the FDA, distributors sell it as a chemical meant for in-lab research, or animal experimentation in a scientific setting, by researchers
Amazon and Alibaba were put on notice last week when they were asked by Eddie for comment, and that seems to have inspired a scramble at both entities to remove listings for many of the peptides, but not all of them
About a week after my visit, Krause shared his analysis of the peptides Id given him